- Home
- DJCO vs CSTL Comparison
DJCO vs CSTL Comparison
Compare DJCO & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJCO
- CSTL
- Stock Information
- Founded
- DJCO 1987
- CSTL 2007
- Country
- DJCO United States
- CSTL United States
- Employees
- DJCO N/A
- CSTL N/A
- Industry
- DJCO Newspapers/Magazines
- CSTL Medical Specialities
- Sector
- DJCO Consumer Discretionary
- CSTL Health Care
- Exchange
- DJCO Nasdaq
- CSTL Nasdaq
- Market Cap
- DJCO 792.8M
- CSTL 848.1M
- IPO Year
- DJCO N/A
- CSTL 2019
- Fundamental
- Price
- DJCO $570.50
- CSTL $27.98
- Analyst Decision
- DJCO
- CSTL Strong Buy
- Analyst Count
- DJCO 0
- CSTL 7
- Target Price
- DJCO N/A
- CSTL $37.57
- AVG Volume (30 Days)
- DJCO 10.9K
- CSTL 315.1K
- Earning Date
- DJCO 02-13-2025
- CSTL 11-04-2024
- Dividend Yield
- DJCO N/A
- CSTL N/A
- EPS Growth
- DJCO N/A
- CSTL N/A
- EPS
- DJCO 32.61
- CSTL 0.21
- Revenue
- DJCO $71,608,000.00
- CSTL $311,878,000.00
- Revenue This Year
- DJCO N/A
- CSTL $51.36
- Revenue Next Year
- DJCO N/A
- CSTL N/A
- P/E Ratio
- DJCO $17.72
- CSTL $135.05
- Revenue Growth
- DJCO 10.74
- CSTL 62.43
- 52 Week Low
- DJCO $309.22
- CSTL $16.97
- 52 Week High
- DJCO $602.00
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- DJCO 55.60
- CSTL 39.09
- Support Level
- DJCO $562.96
- CSTL $27.51
- Resistance Level
- DJCO $583.14
- CSTL $32.57
- Average True Range (ATR)
- DJCO 12.48
- CSTL 1.55
- MACD
- DJCO -2.99
- CSTL -0.23
- Stochastic Oscillator
- DJCO 61.88
- CSTL 17.49
About DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Journal Technologies segment.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.